[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368814-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-368814-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","usp38-an-important-regulatory-factor-in-tumor-malignant-progression","USP38 - an important regulatory factor in tumor malignant progression","","USP38, a deubiquitinating enzyme member of the DUB family, shows complex, context-dependent effects in cancer progression. This review consolidates current findings, describing USP38’s structural features, its differential expression across malignancies, and its influence on proliferation, migration, invasion, and apoptosis. Mechanistically, USP38 modulates the stability and activity of key tumor-associated proteins including HDAC1/3, LSD1, KLF5, METTL14, c-Myc, and HIF-1α, and affects pathways such as JAK2/STAT3. The article also evaluates USP38 as a therapeutic target, development challenges for specific inhibitors, and future research needs to clarify its biology and clinical relevance.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/usp38-an-important-regulatory-factor-in-tumor-malignant-progression/368814/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/usp38-an-important-regulatory-factor-in-tumor-malignant-progression/368814.png","ImageObject",300,407,{"name":42,"@type":43},"Elsa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is USP38 and what role does it play in cancer progression?","Question",{"text":62,"@type":63},"USP38 is a ubiquitin-specific deubiquitinating enzyme (DUB) member. It functions in a dual, context-dependent manner as both an oncogene and a tumor suppressor across different cancers.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Which cellular processes are influenced by USP38?",{"text":67,"@type":63},"USP38 impacts key processes including proliferation, migration, invasion, and apoptosis.",{"name":69,"@type":60,"acceptedAnswer":70},"How does USP38 exert its regulatory mechanisms?",{"text":71,"@type":63},"USP38 regulates the stability and activity of critical proteins involved in tumorigenesis and influences signaling pathways such as JAK2/STAT3.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},368814,1791535359,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Review  \nPUBLISHED 27 August 2025  \nDOI 10.3389/fimmu.2025.1612723  \nOPEN ACCESS  \nEDITED BY  \nAristotle A. Chatziioannou,  \nBiomedical Research Foundation of the Academy of Athens (BRFAA), Greece  \nREVIEWED BY  \nBikesh Kumar Nirala,  \nEmory University, United States Xiaowei Wu,  \nDana–Farber Cancer Institute, United States Yongshuo Liu,  \nPeking University, China  \n*CORRESPONDENCE  \nXiangcai Wang  \n [wangxiangcai@csco.ac.cn](wangxiangcai@csco.ac.cn)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 16 April 2025  \nACCEPTED 12 August 2025  \nPUBLISHED 27 August 2025  \nCITATION  \nLi J, Zhong J, Ye J, Xiang Y, Yi Q, Zhu G, Deng S and Wang X (2025)  \nUSP38: an important regulatory factor in tumor malignant progression.  \nFront. Immunol. 16:1612723 .  \ndoi: 10.3389/fimmu.2025.1612723  \nCOPYRIGHT  \n© 2025 Li, Zhong, Ye, Xiang, Yi, Zhu, Deng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUSP38: an important regulatory factor in tumor malignant progression  \nJunyan Li 1†, Jinghua Zhong 2,3†, Jianming Ye 2,3†, Yi Xiang 2,3†, Qiang Yi 1†, Gangfeng Zhu 1†, Shifan Deng 1†  \nand Xiangcai Wang 2,3*†  \n1The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, China, 2The Oncology Department of the First Afﬁliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China, 3Jiangxi Clinical Research Center for Cancer, Ganzhou, Jiangxi, China  \nUbiquitin-Speciﬁc Protease 38 (USP38), a member of the deubiquitinating enzyme (DUB) family, exhibits a complex and context-dependent role in cancer progression. This review summarizes current research on USP38, highlighting its dual functionality as both an oncogene and a tumor suppressor in various malignancies. We detail the structural characteristics of USP38, its differential expression patterns across cancer types, and its impact on key cellular processes including proliferation, migration, invasion, and apoptosis. Mechanistically, USP38 regulates the stability and activity of crucial proteins involved in tumorigenesis, such as HDAC1/3, LSD1, KLF5, METTL14, c-Myc, and HIF-1a, as well as inﬂuencing signaling pathways like JAK2/STAT3 . The intricate interplay and, in some instances feedback loops, between USP38 and its targets underscore its multifaceted role. Finally, we discuss the potential of USP38 as a therapeutic target, the challenges in developing speciﬁc inhibitors, and future research directions to fully elucidate its complex biology and clinical implications.  \nKEYWORDS  \nUSP, USP38, deubiquitination, expression, mechanism, malignancy  \n1 Introduction  \nCancer remains the primary threat to human life and health, with patients facing not only the substantial physical and mental suffering caused by tumors, but also the considerable economic burden and a severely compromised quality of life (1–6) . Throughout the treatment process for cancer patients, individual differences, tumor heterogeneity, and the limitations of treatment regimens contribute to a decreased sensitivity of tumors to drugs, resulting in suboptimal treatment outcomes and poor prognosis (7) . Therefore, identifying new targets for effective cancer treatment has become an urgent priority. Exploring the regulation of tumor gene-encoded protein homeostasis has become a research hotspot, as the regulation of abnormal protein expression involves numerous molecules, providing potential for precision medicine in cancer therapy (8) .  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nGiven that deubiquitinating activity can effectively ","cbCaihwqdoiKlHqW","https://ap.wps.com/l/cbCaihwqdoiKlHqW","pdf",4521874,16,"English","# Introduction\n## Deubiquitinating enzymes and protein stability\n## USP38 overview","[{\"question\":\"What is USP38 and what role does it play in cancer progression?\",\"answer\":\"USP38 is a ubiquitin-specific deubiquitinating enzyme (DUB) member. It functions in a dual, context-dependent manner as both an oncogene and a tumor suppressor across different cancers.\"},{\"question\":\"Which cellular processes are influenced by USP38?\",\"answer\":\"USP38 impacts key processes including proliferation, migration, invasion, and apoptosis.\"},{\"question\":\"How does USP38 exert its regulatory mechanisms?\",\"answer\":\"USP38 regulates the stability and activity of critical proteins involved in tumorigenesis and influences signaling pathways such as JAK2/STAT3.\"}]","USP38 - an important regulatory factor in tumor malignant progression | PDF",1790178756,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/310041a5138732de29f63af827935af3.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be2c033364b70ad06626475d0640e353.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38c18b30abaacc41ac63f0dbc2927649.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e52c7eace6dda68f9880f3539c0c7e2.webp",980,1385]